Showing results (31-40 of 55) with videos related to
Sort By:
Pageof 6
Journal of Hepatology|February 1, 2014
Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trialJean Marc Perarnau, Amélie Le Gouge, Charlotte Nicolas, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 6, 2015
Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver TransplantationVincent Leroy, Jérôme Dumortier, Audrey Coilly, et al.The New England Journal of Medicine|March 21, 2014
Ribavirin for chronic hepatitis E virus infection in transplant recipientsNassim Kamar, Jacques Izopet, Simona Tripon, et al.Journal of Hepatology|November 24, 2022
Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohortAlexandre Louvet, Valérie Bourcier, Isabelle Archambeaud, et al.Diagnostic and Interventional Imaging|February 5, 2023
Left gastric vein embolization during TIPS placement for acute variceal bleeding has no effect on bleeding recurrence: Results of a multicenter studyPaul Calame, Mathieu Rostam, Louis d'Alteroche, et al.Journal of Hepatology|September 11, 2024
Non-invasive assessment of severe liver fibrosis in patients with Fontan-associated liver disease: The VALDIG-EASL FONLIVER cohortLuis Téllez, Diego Rincón, Audrey Payancé, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 9, 2017
Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programmeChristophe Hézode, Pascal Lebray, Victor De Ledinghen, et al.European Journal of Clinical Pharmacology|August 7, 2019
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohortAurélie Barrail-Tran, Lauriane Goldwirt, Thibaut Gelé, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 28, 2016
Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantationJérôme Dumortier, Vincent Leroy, Christophe Duvoux, et al.Clinics and Research in Hepatology and Gastroenterology|August 25, 2016
Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT)Hélène Fontaine, Marianne Maynard, Cécile Bouix, et al.Pageof 6